Life Science and Lab Space Financing: A Broker's Guide

Life science and lab space financing follows the same stages as other commercial property, with construction or conversion debt first and permanent debt at stabilization, but lenders weigh four things much more heavily: whether the building sits in an established research cluster, whether its physical specifications truly support lab use, how well funded the tenants are, and whether the sponsor has delivered lab projects before. Leverage is generally more conservative than on conventional property and depends strongly on the market.

What Makes Lab Space Different

These differences cut both ways. Tenants that have invested heavily in a fit-out are less likely to move, which supports renewal. But the same fit-out is expensive to rebuild for the next tenant, and a building that falls short on height, power or structure cannot easily be fixed.

The Financing Stages

Construction and Conversion Loans

Banks and debt funds finance ground-up lab buildings and office-to-lab conversions. Lenders commonly want meaningful pre-leasing or, for speculative projects, a strong sponsor and a deep local tenant market. Loans fund in draws and are sized on loan-to-cost and on the projected stabilized value. See the construction loan entry and getting construction loans closed.

Tenant improvement costs deserve their own line in the budget. Lenders want to know how much is funded by the landlord, how much by the tenant, and how landlord-funded improvements are recovered through rent.

Bridge Loans

A bridge loan carries a building through lease-up or re-tenanting. In markets with elevated vacancy, lenders size these conservatively and may require reserves for interest, leasing costs and tenant improvements.

Permanent Loans

Stabilized lab buildings leased to established tenants on long terms are sought after by life companies, and larger assets are financed through CMBS, including single-asset transactions. Buildings leased to early-stage tenants on shorter terms are harder to place with permanent lenders and may stay with banks or debt funds.

What Lenders Underwrite

The Cluster

Life science demand concentrates where research talent, universities, hospitals and venture capital already are. Established clusters include the Boston and Cambridge area, the San Francisco Bay Area, San Diego, Raleigh-Durham, the Washington and Maryland corridor, Philadelphia, Seattle, New Jersey and New York. Lenders give far more credit to a building inside a proven cluster than to one in a market trying to create one.

Market conditions matter as much as the cluster's reputation. Several major markets added a large amount of lab space in recent years while venture funding slowed, pushing vacancy up. Bring current vacancy, absorption and construction pipeline data, and expect lenders to stress the lease-up assumptions.

Building Specifications

An engineering or lab planning report should confirm floor-to-floor heights, structural capacity, mechanical and exhaust capacity, power, emergency generation, loading and freight elevators. For conversions this report is the gating item. A building marketed as "lab-capable" without one will not get far.

Tenant Credit and Funding

For established pharmaceutical and research tenants, lenders review financial statements in the usual way. For venture-backed tenants, they look at cash runway, investor quality, development stage and lease security such as letters of credit. Tenant concentration matters: a building leased to one early-stage company carries more risk than one with several tenants at different stages.

Lease Terms

Lease length relative to the loan term, who owns the improvements, restoration obligations and the amount of landlord-funded tenant improvements all affect value and re-leasing risk.

Sponsor Experience

Lab development and operation are specialized. Lenders strongly prefer sponsors who have built or converted lab space before, with a design and construction team that has done the same.

Key Metrics

• Loan-to-cost during construction, with tenant improvements included in cost.
• Debt yield on stabilized NOI, used as the exit test. See the debt yield calculator.
• DSCR at the expected permanent rate. See the DSCR calculator.
• Weighted average lease term against the loan term.

How Brokers Should Position a Lab Deal

• Open with the cluster and the building's position in it, supported by current market data.
• Include the engineering report on building specifications.
• Break out base building cost and tenant improvement cost separately.
• Summarize each tenant: stage, funding, runway, lease term and security.
• Document the sponsor's completed lab projects.
• State the takeout plan and which permanent lenders the stabilized building would fit.

Related guides: bridge loans for office-to-residential conversion, the broker's guide to office finance, healthcare finance and data center financing, another asset class where the building's infrastructure drives the loan.

Find Life Science Lenders on Janover Pro

Lender appetite for lab space varies sharply by market and by stage. Janover Pro lets brokers search commercial lenders by property type, loan type, size and location and contact originators directly.

Frequently Asked Questions